↓ Skip to main content

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

Overview of attention for article published in eClinicalMedicine, January 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
4 news outlets
policy
2 policy sources
twitter
60 X users
patent
1 patent
reddit
1 Redditor

Readers on

mendeley
198 Mendeley